Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | GFER | P55789 | 1/20 | 0.53 |
| ▸ | CNR2 | P34972 | 8/20 | 0.45 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.40 |
| ▸ | RARA | P10276 | 1/20 | 0.39 |
| ▸ | RARB | P10826 | 1/20 | 0.39 |
| ▸ | RARG | P13631 | 1/20 | 0.39 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | TDO2 | P48775 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11645079 | 0.93 | KMT2A (0.47) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL3976437 | 0.83 | LMNA (0.42) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL27199185 | 0.79 | MEN1 (0.56) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL549830 | 0.77 | MEN1 (0.58) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL4582054 | 0.77 | ALDH1A1 (0.39) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL27199177 | 0.75 | POLB (0.51) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL4823510 | 0.75 | MEN1 (0.44) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL548727 | 0.74 | MEN1 (0.63) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL2002660 | 0.73 | KMT2A (0.53) | KMT2AMEN1GAAPOLBGFER | |
| SCHEMBL1913997 | 0.73 | FAAH (0.55) | KMT2AMEN1GAACNR2FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240124501-A1 | VANADIUM COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | COLORADO STATE UNIVERSITY RESEARCH FOUNDATION | 2024-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240124501-A1 | VANADIUM COMPOUNDS AND METHODS OF MAKING AND USING THEREOF | ATP6V1B2, MVD, VDAC3 | KMT2A 1389/4885MEN1 510/4885GAA 868/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.